http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0635267-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdac295d83591ce68e97c1d85715379d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20 |
| filingDate | 1994-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29a5a8e37255fb8c6b71780f2d398595 |
| publicationDate | 1995-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0635267-A1 |
| titleOfInvention | Compositions containing fatty acids with antiinflammatory activity |
| abstract | These compositions contain, as main active principle, in a pharmaceutically acceptable carrier, one or more salts of one or more fatty acids having the general formula: CH₃ - C x ..H y ..O z - COO⁻ X⁺ in which x = 2 to 30, y = 2 to 60, z = 0 to 6 and X⁺ is the cation of the base used (preferably soda or potash)n n n The fatty acids are chosen from those derived from natural substances, and in particular oils and fats of animal or vegetable origin. The fatty acid salt (s) may be associated with one or more steroidal or non-steroidal anti-inflammatory drugs.n n n These compositions are intended for application by parenteral route, by oral route, by rectal route, by diathelic route, as well as by dermal and intradermal route. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0209524-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6712952-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7414077-B2 |
| priorityDate | 1993-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.